Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Physiological Study to Assess Mechanism of Action of MOBIDERM® in Lower-limb Lymphedema Patients

NCT04252690 is registered in ClinicalTrials.gov with Thuasne as lead sponsor.

NCT NCT04252690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04252690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Physiological Study to Assess Mechanism of Action of MOBIDERM® in Lower-limb Lymphedema Patients
Lead sponsor
Thuasne
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2020
Completion date
June 23, 2022
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphedema congenital, lymphedema of leg, lymphedema primary, lymphedema, secondary